未登录 Development and validation of a plasma miRNA-CEA biomarker panel for early detection of lung cancer 血浆miRNA-CEA生物标志物面板的开发与验证用于肺癌的早期检测 Samejima, Joji; Zhou, Li; Kimura, Toru; Jin, Yu; Tanaka, Yugo; Kobayashi, Susumu; Miyata, Yoshiharu; Gu, Minxia; Lim, Jeremy; Mukai, Mikio; Nagao, Takuya; Chan, Suit-Fong; Yoong, Li Foong; Matsuoka, Hiroshi; Okami, Jiro; Cheng, He; Tsuboi, Masahiro 分享 收藏
分享 收藏
UBE2T silencing suppresses proliferation and induces cell cycle arrest and apoptosis in bladder cancer cells (vol 12, pg 4485, 2016) UBE2T沉默抑制膀胱癌细胞增殖并诱导细胞周期停滞和凋亡(vol 12, pg 4485, 2016) Gong, Yan Qing; Peng, Ding; Ning, Xiang Hui; Yang, Xin Yu; Li, Xue Song; Zhou, Li Qun; Guo, Ying Lu 分享 收藏
分享 收藏
Immunological landscape of radiation-induced cardiac injury 辐射诱导的心脏损伤的免疫学景观 Liu, Huan; Ou, Dan; Zhao, Han; Wu, Ran; Liao, Keman; Zhao, Jianyi; Li, Zhou; Xu, Zhe; Wang, Yuerui; Cao, Lu; Lin, Yingying; Chen, Jia-yi 分享 收藏
分享 收藏
PTTG1IP Orchestrates Epithelial-Mesenchymal Transition and DNA Damage Response in Thyroid Cancer Progression PTTG1IP 调控甲状腺癌进展中的上皮-间质转化和DNA损伤应答 Zhang, Henglu; Zhou, Li; Wang, Suyu; Yao, Di; Ma, Jun; Hu, Xiaoyan; Zhang, Wencheng; Tao, Mengyuan; Wang, Min; Lu, Weiping 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase Ib/II dose-escalation and dose-expansion study Disitamab vedotin联合toripalimab治疗局部晚期或转移性尿路上皮癌 (RC48-C014): Ib/II期剂量递增和剂量扩展研究 Zhou, L.; Yang, K. W.; Zhang, S.; Yan, X. Q.; Li, S. M.; Xu, H. Y.; Li, J.; Liu, Y. Q.; Tang, B. X.; Chi, Z. H.; Si, L.; Cui, C. L.; Guo, H. Q.; He, Z. S.; Guo, J.; Sheng, X. 分享 收藏
分享 收藏
Ultrahigh Exchange Bias Field/Coercive Field Ratio in In Situ Formed Two-Dimensional Magnetic Te-Cr2O3/Cr5Te6 Heterostructures 二维磁性Te-Cr2O3/Cr5Te6异质结构中极高的交换偏置场/矫顽场比率 Yi, C; Li, Z; Li, QQ; Li, BL; Zhang, HM; He, K; Zhang, LQ; Zhang, ZC; Feng, Y; Liu, YY; Liu, MM; Wang, D; Li, SH; Tang, JM; Gao, P; Zhu, ML; Wang, YR; Wu, RX; Li, J; Liu, XQ; Chen, SL; Ma, C; Liu, Y; Wei, ZM; Liao, L; Li, B; Duan, XD 分享 收藏
分享 收藏
Immunogenicity and safety of two-dose or three-dose regimens of inactivated COVID-19 vaccines in patients with pulmonary tuberculosis: a randomised clinical trial 两剂或三剂灭活新型冠状病毒肺炎疫苗在肺结核患者中的免疫原性和安全性: 一项随机临床试验 Jin, Pengfei; Liu, Qiao; Chen, Wenli; Guo, Xilin; Jiang, Hongmei; Zhang, Ruimei; Ding, Mingdong; Zhang, Kui; Cao, Zhaolan; He, Jiexiao; Jia, Siyue; Wei, Mingwei; Hu, Yuansheng; Cui, Lunbiao; Wang, Jianfeng; Li, Zhuopei; Zhang, Xiaoyin; Xia, Xin; Wu, Yanfei; Zhou, Li; Zhu, Yawen; Gao, Chunjing; Zhang, Tiantian; Zhu, Fengcai; Zeng, Gang; Zhu, Limei; Li, Jingxin 分享 收藏
IBI310 (anti-CTLA-4 antibody) monotherapy or in combination with sintilimab in advanced melanoma or urothelial carcinoma Cui, Chuanliang; Li, Juan; Yang, Yue; Si, Lu; Chi, Zhihong; Mao, Lili; Wang, Xuan; Tang, Bixia; Yan, Xieqiao; Li, Siming; Zhou, Li; Wei, Xiaoting; Shen, Yuping; Guo, Qun; Zheng, Shirui; Guo, Jun; Lian, Bin 分享 收藏
分享 收藏
Dual-task turn velocity - a novel digital biomarker for mild cognitive impairment and dementia Wang, Jing; Zhou, Zheping; Cheng, Shanshan; Zhou, Li; Sun, Xiaoou; Song, Ziyang; Wu, Zhiwei; Lu, Jinhua; Qin, Yiren; Wang, Yueju 分享 收藏
分享 收藏